Södertälje, Sweden

Wei Tian

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Mimetogen Pharmaceuticals, Inc, Astrazeneca Ab. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Tian. Retrieved from https://idiyas.com/inventor/wei-tian-93b5x3hg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 80.0

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Södertälje, SE (2004 - 2018)
  • Sodertalje, SE (2021 - 2023)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Wei Tian: Innovator in Peptidomimetic Cyclic Salts

Introduction

Wei Tian is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of chemistry, particularly in the synthesis of peptidomimetic compounds. With a total of 5 patents to his name, his work has advanced the understanding and application of cyclic salts.

Latest Patents

Wei Tian's latest patents focus on the solution phase synthesis of β-turn peptidomimetic cyclic salts. The present disclosures relate to methods of preparing and crystallizing β-turn cyclic peptidomimetic salts of a specific formula. These methods provide a more efficient route for preparing a crystalline form of β-turn cyclic peptidomimetic compounds and their salts.

Career Highlights

Throughout his career, Wei Tian has worked with prominent companies in the pharmaceutical industry, including Mimetogen Pharmaceuticals, Inc. and AstraZeneca AB. His experience in these organizations has allowed him to develop innovative solutions in drug design and synthesis.

Collaborations

Wei Tian has collaborated with esteemed colleagues such as Sébastien Rocchi and Chantal Devin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Wei Tian's contributions to the field of peptidomimetic cyclic salts demonstrate his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence the pharmaceutical industry and inspire future research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…